Sign In
Buy RXRX
$3.52
+0.180 (+5.39%)
At Close: Jun 26, 2026
Why Recursion Pharmaceuticals Stock Tanked on Tuesday
06:21pm, Tuesday, 05'th Aug 2025
Before market open on Tuesday, Recursion Pharmaceuticals (RXRX -4.74%) published its latest set of quarterly earnings and business update. It might have wished it hadn't, as those quarterly numbers cl
Recursion (RXRX) Q2 Revenue Jumps 33%
04:57pm, Tuesday, 05'th Aug 2025
Recursion (RXRX) Q2 Revenue Jumps 33%
Recursion Pharmaceuticals, Inc. (RXRX) Q2 2025 Earnings Call Transcript
02:44pm, Tuesday, 05'th Aug 2025
Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX ) Q2 2025 Earnings Conference Call August 5, 2025 8:00 AM ET Company Participants Ben R. Taylor - CFO & President of Recursion UK Christopher C.
Recursion Pharmaceuticals (RXRX) Reports Q2 Loss, Beats Revenue Estimates
08:45am, Tuesday, 05'th Aug 2025
Recursion Pharmaceuticals (RXRX) came out with a quarterly loss of $0.41 per share versus the Zacks Consensus Estimate of a loss of $0.35. This compares to a loss of $0.4 per share a year ago.
Recursion Reports Second Quarter 2025 Financial Results and Provides Business Update
06:30am, Tuesday, 05'th Aug 2025
Company shares partnership and clinical updates including $7 million Sanofi milestone and more information on patient populations for REC-1245 (RBM39) and REC-617 (CDK7) Company shares partnership and
2 Beaten-Down Stocks With Incredible Upside Potential
12:32pm, Sunday, 03'rd Aug 2025
Recent history has, once again, demonstrated that relatively small biotech companies can see their shares soar significantly on positive developments. Summit Therapeutics' stock is up by more than 2,0
Recursion Pharmaceuticals (RXRX) Registers a Bigger Fall Than the Market: Important Facts to Note
06:45pm, Wednesday, 30'th Jul 2025
Recursion Pharmaceuticals (RXRX) closed the most recent trading day at $5.81, moving 2.35% from the previous trading session.
Why Recursion Pharmaceuticals (RXRX) Dipped More Than Broader Market Today
06:51pm, Tuesday, 29'th Jul 2025
In the latest trading session, Recursion Pharmaceuticals (RXRX) closed at $5.95, marking a -5.71% move from the previous day.
Recursion to Report Second Quarter 2025 Business Updates and Financial Results on August 5th
08:00am, Tuesday, 29'th Jul 2025
Salt Lake City, UT, July 29, 2025 (GLOBE NEWSWIRE) -- Recursion (Nasdaq: RXRX), a leading clinical stage TechBio company decoding biology to radically improve lives, announced today it will provide bu
Why Recursion Pharmaceuticals Stock Got Mashed on Monday
06:43pm, Monday, 28'th Jul 2025
Clinical-stage biotech Recursion Pharmaceuticals' (RXRX -2.85%) stock took it on the chin in the first trading day of the week. Monday saw investors back out of the company's shares, leaving them with
Tempus AI (TEM) vs. Recursion (RXRX): Which AI Biotech Stock Is Better?
12:20pm, Monday, 28'th Jul 2025
Tempus AI and Recursion Pharmaceuticals are fine ways to play the AI revolution from the health angle.
The Median Retirement Savings for American Households Is $87,000. Here Are 3 Incredible Stocks to Buy Now and Hold for Decades.
06:14pm, Saturday, 26'th Jul 2025
Are Americans saving enough money to fund a comfortable retirement? Probably not.
How Palantir, Tempus, Nvidia-Backed Recursion Are Disrupting Big Pharma
01:53pm, Friday, 25'th Jul 2025
Imagine you stepped into the dimly lit hospital meeting room to pitch a new cancer‑diagnostic deal. You flick through slides powered by Palantir Technologies Inc.'s PLTR Foundry platform, showcasing
RXRX vs. RLAY: Which Precision Biotech Stock is a Better Bet Now?
12:36pm, Friday, 25'th Jul 2025
Recursion Pharmaceuticals and Relay Therapeutics both leverage their respective AI drug discovery platforms to potentially develop novel therapeutic candidates.
Recursion Pharmaceuticals (RXRX) Stock Drops Despite Market Gains: Important Facts to Note
06:51pm, Wednesday, 23'rd Jul 2025
Recursion Pharmaceuticals (RXRX) concluded the recent trading session at $6.43, signifying a -1.68% move from its prior day's close.
